Patent Settlements for Generic Drugs

Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The Supreme Court recently ruled that these deals are subject to anti-trust scrutiny.

*The transcript for this program was compiled from uncorrected Closed Captioning.

People in this video

  • Michael Russo Director U.S. Public Interest Research Group->Federal Program
  • Sumanth Addanki Senior Vice President NERA Economic Consulting
More People

Hosting Organization

More information about

Patent Settlements for Generic Drugs

471 Views
Program ID:
314147-1
Category:
Senate Committee
Format:
Senate Committee
Location:
Washington, District of Columbia, United States
First Aired:
Jul 23, 2013
Last Aired:
Jul 29, 2013

Airing Details

  • Jul 23, 2013 | 1:06pm EDT | C-SPAN 2
  • Jul 23, 2013 | 11:56pm EDT | C-SPAN 3
  • Jul 24, 2013 | 6:27am EDT | C-SPAN 3
  • Jul 25, 2013 | 9:23pm EDT | C-SPAN 3
  • Jul 25, 2013 | 11:39pm EDT | C-SPAN 3
  • Jul 26, 2013 | 3:23am EDT | C-SPAN 3
  • Jul 26, 2013 | 5:38am EDT | C-SPAN 3
  • Jul 26, 2013 | 3:26pm EDT | C-SPAN 3
  • Jul 26, 2013 | 5:42pm EDT | C-SPAN 3
  • Jul 29, 2013 | 3:43am EDT | C-SPAN 1
Purchase a DVD or Download

Patent Settlements for Generic Drugs

  • DVD
    Length:
    02:39:48
    Price:
    $29.95
    Add to Cart
  • MP4 video - Standard
    Length:
    02:39:48
    Price:
    $6.99
    Add to Cart
  • MP4 video - Low
    Length:
    02:39:48
    Price:
    $5.99
    Add to Cart
  • MP3 audio
    Length:
    02:39:48
    Price:
    $0.99
    Add to Cart

Clips from This Video